BioSpace News Archive

Business

Novartis Inks Potential $1.5 Billion Parkinson’s Deal with UCB

Novartis held an investor event to discuss their research programs, highlighting its partnership with Belgian pharma company UCB worth up to $1.5 billion.

December 2, 2021
·
2 min read
·
Mark Terry
Drug Development

Study: Isomers May Hold New Clue to Alzheimer’s Disease

Researchers studied the behavior of protein cells in the brain and found a significant difference in those who have had dementia and those who have not, particularly in their ability to clean themselves.

December 2, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

BMS Faces Heat from Employees Over Vaccine Mandate

Four BMS employees have filed a lawsuit against BMS after claiming the company would not grant them a religious exemption and threatened their employment.

December 2, 2021
·
3 min read
·
Alex Keown
Palliative Care Market Size to Reach USD 6.43 Billion in 2028, Noted Reports and Data

Growing need for palliative care due to rising incidence of cancer and lifestyle-related risk factors, significant reduction in healthcare expenses due to implementation of palliative care, and enhanced accessibility to palliative care drugs are some key factors expected to drive market growth.

December 2, 2021
·
8 min read
Business

Mix-and-Match Vaccine Platform May Boost Immune Response & Duration

IDRI is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration.

December 2, 2021
·
4 min read
·
Gail Dutton
Biopharma Companies Working to Battle Climate Change

Climate change has dire effects on the healthcare sector. Read how biopharma companies are tackling climate change.

December 2, 2021
·
6 min read
·
Mishayl Hanan
Drug Development

Is the Pfizer COVID Vaccine Safe for Children Ages 5-11?

It was recently announced that a low dose of the Pfizer-BioNTech vaccine is safe for kids ages 5 to 11.

December 2, 2021
·
4 min read
·
Alina Zahid
Drug Development

Questions About Omicron Remain as First Case Identified in US

The U.S. Centers for Disease Control and Prevention (CDC) reported that the Omicron variant of COVID-19 had been identified in California.

December 2, 2021
·
4 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, Dec. 3

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

December 2, 2021
·
9 min read
·
Alex Keown
Business

Tune Therapeutics Debuts with $40 Million to Fine-Tune the Human Genome

Tune claims TEMPO can rapidly target and adjust the epigenomic machinery, controlling gene expression and dictating how the DNA will be molded.

December 2, 2021
·
2 min read
·
Rosey Alba